Mohammadi et al. reported that the AhR agonist indole-3-carbinol (I3C) mediates AhR activation, contributing to immunoregulatory effects on macrophages of SLE patients by decreasing expression of proinflammatory cytokines and overexpression of anti-inflammatory cytokines [65]. Here, AHR is linked to systemic lupus erythematosus.